Cargando…
Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance
BACKGROUND: The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on quinolone resistance among patients receiving prophylaxis, with very few data reporting its impact on...
Autores principales: | Garnica, Marcia, Nouér, Simone A, Pellegrino, Flávia LPC, Moreira, Beatriz M, Maiolino, Angelo, Nucci, Marcio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729823/ https://www.ncbi.nlm.nih.gov/pubmed/23899356 http://dx.doi.org/10.1186/1471-2334-13-356 |
Ejemplares similares
-
Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing()
por: Garnica, Marcia, et al.
Publicado: (2016) -
Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil
por: Nucci, Marcio, et al.
Publicado: (2013) -
Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
por: Nucci, Marcio, et al.
Publicado: (2014) -
COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals()
por: Garnica, Marcia, et al.
Publicado: (2020) -
Antibacterial prophylaxis in neutropenic children with cancer
por: Barone, Angelica
Publicado: (2011)